Pacific Biosciences Of California (PACB) Retained Earnings (2010 - 2026)

Pacific Biosciences Of California's Retained Earnings history runs 17 years deep, the most recent figure standing at -$147000.0 for Q1 2026.

• In Q1 2026, Retained Earnings fell 138.58% year-over-year to -$147000.0; the TTM figure through Mar 2026 stood at -$147000.0 (down 138.58% YoY), while the FY2025 annual figure was -$2.7 billion, down 25.43% from the prior year.
• Retained Earnings was -$147000.0 for Q1 2026 at Pacific Biosciences Of California, up from -$2.7 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $381000.0 in Q1 2025 to a low of -$2.7 billion in Q4 2025.
• Historically, Retained Earnings has averaged -$1.1 billion across 5 years, with a median of -$1.4 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings sank 22849650.0% in 2022, then surged 151.05% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$1.5 billion in 2022, then decreased by 20.02% to -$1.8 billion in 2023, then dropped by 16.85% to -$2.1 billion in 2024, then slipped by 25.43% to -$2.7 billion in 2025, then jumped by 99.99% to -$147000.0 in 2026.
• The last three Retained Earnings figures came in at -$147000.0 (Q1 2026), -$2.7 billion (Q4 2025), and -$2.7 billion (Q3 2025), per Business Quant data.